Search for Clinical Trial Results
Pancreatic Islet Cell Tumors - 25 Studies Found
| Status | Study |
| Terminated |
Study Name: A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors Condition:
Date: 2007-01-29 Interventions:
|
| Terminated |
Study Name: Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET Condition: Islet Cell Tumor Date: 2011-06-14 Interventions:
|
| Completed |
Study Name: Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors Condition:
Date: 2008-01-25 Interventions:
|
| Completed |
Study Name: RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma Condition:
Date: 2005-06-07 Interventions:
|
| Withdrawn |
Study Name: Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors Condition:
Interventions: |
| Completed |
Study Name: Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization Condition:
Date: 2007-02-09 Interventions:
|
| Completed |
Study Name: PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors Condition:
Date: 2001-06-06 Interventions: Drug: bortezomib |
| Recruiting |
Study Name: Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders Condition:
|
| Recruiting |
Study Name: Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors Condition:
Interventions: Drug: PVA microporous hydrospheres/doxorubicin hydrochloride |
| Completed |
Study Name: AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors Condition:
Interventions: |